Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis
- PMID: 16505020
- DOI: 10.1167/iovs.05-0581
Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis
Abstract
Purpose: Elimination of myofibroblasts after repair of corneal injury is essential for the maintenance of corneal transparency. In the current study, the role of platelet-activating factor (PAF) in combination with tumor necrosis factor (TNF)-alpha in corneal myofibroblast apoptosis was explored.
Methods: Porcine corneal myofibroblasts (PCMs) were obtained from subcultured fibroblasts plated at a low density (5 cells/mm2). Mouse anti-alpha-smooth muscle actin antibody was used to identify the cell phenotype. Immunofluorescence was performed to localize PAF and TNF-alpha receptors in those cells. The reactivity of the antibodies was characterized by Western blot analysis. To induce myofibroblast apoptosis, PCMs were treated for 24 to 72 hours with methylcarbamyl-PAF (cPAF, 300 nM), a nonhydrolyzable PAF analogue, TNF-alpha (20 ng/mL), and TNF-alpha+cPAF, with or without LAU-0901 (150 nM), a novel PAF antagonist. Apoptosis was assayed by Hoechst 33258 and TUNEL staining and DNA laddering. 6-Diamidino-2-phenylindole (DAPI) was used for nuclear counterstaining. Images were recorded by fluorescence microscope.
Results: Immunofluorescence with a PAF-receptor (N terminus) polyclonal antibody showed that the receptor was expressed in both plasma and nuclear membranes of myofibroblasts. TNF-alpha receptor II (TNF-RII) was localized in the cytoplasm, whereas TNF-receptor I (TNF-RI) was found in both cytoplasm and plasma membrane. Treatment with TNF-alpha for 24, 48, and 72 hours induced apoptosis in 18%, 24%, and 32%, respectively, of the myofibroblasts. Western blot analysis showed expression of single bands corresponding to the molecular weights of the receptors. Treatment with cPAF induced apoptosis in 10%, 18%, and 26% of the cells, respectively. However, treatment with both cytokines induced apoptosis in 42%, 78%, and 86%, respectively, of the cells, demonstrating a synergistic action between PAF and TNF-alpha. Blocking the PAF receptor with LAU-0901 inhibited the synergistic effect induced by PAF.
Conclusions: Corneal myofibroblasts express a PAF receptor in the nuclear membrane, and they also express TNF-RI and RII. The synergistic effect on myofibroblast apoptosis by PAF and TNF-alpha suggests that during corneal stromal wound healing, PAF acting in conjunction with other cytokines could play an important role in eliminating these cells.
Similar articles
-
Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB.Invest Ophthalmol Vis Sci. 2000 May;41(6):1327-36. Invest Ophthalmol Vis Sci. 2000. PMID: 10798647
-
Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist.J Cataract Refract Surg. 2004 Apr;30(4):884-91. doi: 10.1016/j.jcrs.2003.09.069. J Cataract Refract Surg. 2004. PMID: 15093656
-
PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.Invest Ophthalmol Vis Sci. 2005 Feb;46(2):487-96. doi: 10.1167/iovs.04-0852. Invest Ophthalmol Vis Sci. 2005. PMID: 15671273
-
Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors.Endothelium. 2005 Jan-Apr;12(1-2):63-72. doi: 10.1080/10623320590933815. Endothelium. 2005. PMID: 16036317 Review.
-
Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.Curr Opin Investig Drugs. 2001 Jan;2(1):136-8. Curr Opin Investig Drugs. 2001. PMID: 11527006 Review.
Cited by
-
LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.Brain Res. 2009 Feb 9;1253:184-90. doi: 10.1016/j.brainres.2008.11.074. Epub 2008 Dec 3. Brain Res. 2009. PMID: 19070607 Free PMC article.
-
Role of platelet-activating factor in cell death signaling in the cornea: A review.Mol Neurobiol. 2010 Aug;42(1):32-8. doi: 10.1007/s12035-010-8129-1. Epub 2010 Apr 30. Mol Neurobiol. 2010. PMID: 20431963 Free PMC article. Review.
-
Expressions of tumor necrosis factor-α, its receptor I, II and receptor-associated factor 2 in the porcine corpus luteum during the estrous cycle and early pregnancy.Vet Res Commun. 2014 Mar;38(1):1-10. doi: 10.1007/s11259-013-9575-9. Epub 2013 Sep 22. Vet Res Commun. 2014. PMID: 24057858
-
Corneal stromal wound healing: Major regulators and therapeutic targets.Ocul Surf. 2021 Jan;19:290-306. doi: 10.1016/j.jtos.2020.10.006. Epub 2020 Oct 28. Ocul Surf. 2021. PMID: 33127599 Free PMC article. Review.
-
Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth.Front Pharmacol. 2021 Sep 24;12:746470. doi: 10.3389/fphar.2021.746470. eCollection 2021. Front Pharmacol. 2021. PMID: 34630114 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources